| GC33399-10mg |
|
221877-56-1 |
42-(2-Tetrazolyl)rapamycin
|
0 |
C52H79N5O12 |
|
|
|
| GC33399-5mg |
|
221877-56-1 |
42-(2-Tetrazolyl)rapamycin
|
0 |
C52H79N5O12 |
|
|
|
| GC33399-2mg |
|
221877-56-1 |
42-(2-Tetrazolyl)rapamycin
|
0 |
C52H79N5O12 |
|
|
|
| GC33399-1mg |
|
221877-56-1 |
42-(2-Tetrazolyl)rapamycin
|
0 |
C52H79N5O12 |
|
|
|
| GC33399-10mM(1mLinDMSO) |
|
221877-56-1 |
42-(2-Tetrazolyl)rapamycin
|
0 |
C52H79N5O12 |
|
|
|
| GC33398-25mg |
|
2097262-60-5 |
|
0 |
C24H24N4O |
|
|
|
| GC33398-10mg |
|
2097262-60-5 |
|
0 |
C24H24N4O |
|
|
|
| GC33398-5mg |
|
2097262-60-5 |
|
0 |
C24H24N4O |
|
|
|
| GC33396-100mg |
|
302-84-1 |
|
0 |
C3H7NO3 |
|
|
|
| GC33394-100mg |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer)
|
0 |
C23H18FN5O2 |
|
|
|
| GC33394-50mg |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer)
|
0 |
C23H18FN5O2 |
|
|
|
| GC33394-25mg |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer)
|
0 |
C23H18FN5O2 |
|
|
|
| GC33394-10mg |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer)
|
0 |
C23H18FN5O2 |
|
|
|
| GC33394-5mg |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer)
|
0 |
C23H18FN5O2 |
|
|
|
| GC33394-1mg |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer)
|
0 |
C23H18FN5O2 |
|
|
|
| GC33394-10mM(1mLinDMSO) |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer)
|
0 |
C23H18FN5O2 |
|
|
|
| GC33392-20mg |
|
1278405-51-8 |
|
0 |
C18H19ClFN5OS |
|
|
|
| GC33392-10mg |
|
1278405-51-8 |
|
0 |
C18H19ClFN5OS |
|
|
|
| GC33392-5mg |
|
1278405-51-8 |
|
0 |
C18H19ClFN5OS |
|
|
|
| GC33392-1mg |
|
1278405-51-8 |
|
0 |
C18H19ClFN5OS |
|
|
|
